Oxford, Oxfordshire, United KingdomFounded 201967+ employeesPrivate
$39.8M raisedSeries A· last: series a (Oct 2022)· 4 rounds
Backed by(21 investors)
Khosla Ventures · Lead+12 more
Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications. To learn more, please visit www.ochre-bio.com.
